Effect of KRAS and NRAS mutations on the prognosis of patients with synchronous metastatic colorectal cancer presenting with liver-only and lung-only metastases

It has been reported that 20–25% of patients with colorectal cancer (CRC) have metastases at the time of diagnosis. Liver and lung are the most common metastatic sites. The aim of the present study was to investigate the association of KRAS and NRAS mutations with clinicopathological features and pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chuang, Shih-Chang, Huang, Ching-Wen, Chen, Yi-Ting, Ma, Cheng-Jen, Tsai, Hsiang-Lin, Chang, Tsung-Kun, Su, Wei-Chih, Hsu, Wen-Hung, Kuo, Chao-Hung, Wang, Jaw-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400335/
https://www.ncbi.nlm.nih.gov/pubmed/32782529
http://dx.doi.org/10.3892/ol.2020.11795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400335/
https://www.ncbi.nlm.nih.gov/pubmed/32782529
http://dx.doi.org/10.3892/ol.2020.11795

Ejemplares similares